These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 31244868)

  • 1. Critical Analysis of the Commercial Potential of Plants for the Production of Recombinant Proteins.
    Schillberg S; Raven N; Spiegel H; Rasche S; Buntru M
    Front Plant Sci; 2019; 10():720. PubMed ID: 31244868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plant molecular farming for the production of valuable proteins - Critical evaluation of achievements and future challenges.
    Schillberg S; Finnern R
    J Plant Physiol; 2021; 258-259():153359. PubMed ID: 33460995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant plant-derived pharmaceutical proteins: current technical and economic bottlenecks.
    Sabalza M; Christou P; Capell T
    Biotechnol Lett; 2014 Dec; 36(12):2367-79. PubMed ID: 25048244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commercial aspects of pharmaceutical protein production in plants.
    Fischer R; Schillberg S; Buyel JF; Twyman RM
    Curr Pharm Des; 2013; 19(31):5471-7. PubMed ID: 23394566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities for recombinant antigen and antibody expression in transgenic plants--technology assessment.
    Schillberg S; Twyman RM; Fischer R
    Vaccine; 2005 Mar; 23(15):1764-9. PubMed ID: 15734038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraction and downstream processing of plant-derived recombinant proteins.
    Buyel JF; Twyman RM; Fischer R
    Biotechnol Adv; 2015 Nov; 33(6 Pt 1):902-13. PubMed ID: 25922318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Protein Production in Plants: A Brief Overview of Strengths and Challenges.
    Schillberg S; Spiegel H
    Methods Mol Biol; 2022; 2480():1-13. PubMed ID: 35616854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production.
    Shanmugaraj B; I Bulaon CJ; Phoolcharoen W
    Plants (Basel); 2020 Jul; 9(7):. PubMed ID: 32635427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Process Development Strategies in Plant Molecular Farming.
    Buyel JF
    Curr Pharm Biotechnol; 2015; 16(11):966-82. PubMed ID: 26343135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant-based production of biopharmaceuticals.
    Fischer R; Stoger E; Schillberg S; Christou P; Twyman RM
    Curr Opin Plant Biol; 2004 Apr; 7(2):152-8. PubMed ID: 15003215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the verge of the market - Plant factories for the automated and standardized production of biopharmaceuticals.
    Huebbers JW; Buyel JF
    Biotechnol Adv; 2021; 46():107681. PubMed ID: 33326816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in plant molecular farming.
    Obembe OO; Popoola JO; Leelavathi S; Reddy SV
    Biotechnol Adv; 2011; 29(2):210-22. PubMed ID: 21115109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular farming of human cytokines and blood products from plants: challenges in biosynthesis and detection of plant-produced recombinant proteins.
    da Cunha NB; Vianna GR; da Almeida Lima T; Rech E
    Biotechnol J; 2014 Jan; 9(1):39-50. PubMed ID: 24376137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Different Perspective: How Much Innovation Is Really Needed for Monoclonal Antibody Production Using Mammalian Cell Technology?
    Kelley B; Kiss R; Laird M
    Adv Biochem Eng Biotechnol; 2018; 165():443-462. PubMed ID: 29721583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular farming of recombinant antibodies in plants.
    Schillberg S; Fischer R; Emans N
    Cell Mol Life Sci; 2003 Mar; 60(3):433-45. PubMed ID: 12737305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical Evaluation of Strategies for the Production of Blood Coagulation Factors in Plant-Based Systems.
    Top O; Geisen U; Decker EL; Reski R
    Front Plant Sci; 2019; 10():261. PubMed ID: 30899272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharming and transgenic plants.
    Liénard D; Sourrouille C; Gomord V; Faye L
    Biotechnol Annu Rev; 2007; 13():115-47. PubMed ID: 17875476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in plantibody technology.
    Stoger E; Sack M; Nicholson L; Fischer R; Christou P
    Curr Pharm Des; 2005; 11(19):2439-57. PubMed ID: 16026298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems.
    Pogue GP; Vojdani F; Palmer KE; Hiatt E; Hume S; Phelps J; Long L; Bohorova N; Kim D; Pauly M; Velasco J; Whaley K; Zeitlin L; Garger SJ; White E; Bai Y; Haydon H; Bratcher B
    Plant Biotechnol J; 2010 Jun; 8(5):638-54. PubMed ID: 20514694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of plants to produce recombinant protein products.
    Park KY; Wi SJ
    J Plant Biol; 2016; 59(6):559-568. PubMed ID: 32288513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.